Improvements in Survival and Disparities for Advanced-Stage Laryngeal Cancer

被引:23
|
作者
LeBlanc, Blake Joseph [1 ]
Shi, Runhua [2 ]
Mehta, Vikas [1 ]
Mills, Glenn [3 ]
Ampil, Federico [4 ]
Nathan, Cherie-Ann O. [1 ]
机构
[1] Louisiana State Univ Hlth Shreveport, Dept Otolaryngol Head & Neck Surg, Shreveport, LA USA
[2] Louisiana State Univ Hlth Shreveport, Dept Med, Shreveport, LA USA
[3] Louisiana State Univ Hlth Shreveport, Dept Oncol, Shreveport, LA USA
[4] Louisiana State Univ Hlth Shreveport, Dept Radiat Oncol, Shreveport, LA USA
关键词
SQUAMOUS-CELL CARCINOMA; ORGAN PRESERVATION; CARTILAGE INVASION; TRENDS; CHEMOTHERAPY; STRATEGIES; SURGERY; CARE;
D O I
10.1001/jamaoto.2014.2998
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
IMPORTANCE Laryngeal cancer survival rates have declined over the past 2 decades. Primary surgical therapy may increase survival rates in advanced-stage tumors. OBJECTIVE To compare survival outcomes for initial surgical treatment of advanced-stage primary tumors in the Louisiana health system with outcomes in the National Cancer Database (NCDB). DESIGN, SETTING, AND PARTICIPANTS Retrospective analysis was conducted at an academic tertiary referral hospital. Patients diagnosed as having laryngeal carcinoma between 1998 and 2007 were identified via a tumor registry. Louisiana State University Health-Shreveport (LSU Health) data and national data from 2000 to 2010 were obtained from the NCDB of the American College of Surgeons. INTERVENTIONS Treatment of laryngeal cancer. MAIN OUTCOMES AND MEASURES Age, sex, race/ethnicity, socioeconomic status, laryngeal subsite, stage, primary treatment modality, and observed survival were analyzed and compared. RESULTS A total of 165 patients treated at LSU Health met the inclusion criteria. One hundred seventeen (70.91%) presented with advanced-stage (III/IV) disease, compared with 46.67% nationwide (P < .01). For stage IV disease our 5-year survival rate was 55.54%(95% CI, 43.35%-66.11%) compared with 31.60% (95% CI, 30.40%-32.90%) nationally (P < .05). Our proportion of uninsured patients was 23.73% vs 5.05% of patients nationally (P < .001), and our patients traveled further distances for care with 60.47% traveling 50 miles or more, compared with 15.87% nationally (P < .001). Sixty-four of the patients with advanced-stage disease (54.70%) underwent primary surgical therapy to include total laryngectomy. Data from the NCDB indicate that the rate of laryngectomy declined from 40% to 60% in the 1980s to 32% in 2007. CONCLUSIONS AND RELEVANCE Louisiana State University Health-Shreveport treated more uninsured patients with advanced-stage laryngeal cancer compared with national data but demonstrated higher survival rates for those with advanced-stage disease. The results also demonstrate that we have continued a high rate of primary surgical therapy for advanced-stage disease, despite the national trend toward organ preservation. We believe that upfront laryngectomy may explain our higher survival rates for advanced-stage laryngeal cancer.
引用
收藏
页码:169 / 173
页数:5
相关论文
共 50 条
  • [31] Development and validation of radiomic signature for predicting overall survival in advanced-stage cervical cancer
    Jha, Ashish Kumar
    Mithun, Sneha
    Sherkhane, Umeshkumar B.
    Jaiswar, Vinay
    Shah, Sneha
    Purandare, Nilendu
    Prabhash, Kumar
    Maheshwari, Amita
    Gupta, Sudeep
    Wee, Leonard
    Rangarajan, V.
    Dekker, Andre
    FRONTIERS IN NUCLEAR MEDICINE, 2023, 3
  • [32] Predictive and prognostic values of pretreatment functional imaging-based biomarkers in advanced-stage laryngeal cancer
    Eskiizmir, Gorkem
    Ovali, Gulgun Yilmaz
    Aras, Feray
    Ozyurt, Beyhan Cengiz
    Tarhan, Serdar
    ENT UPDATES, 2018, 8 (01): : 1 - 12
  • [33] Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer
    Jung, Ah Ra
    Roh, Jong-Lyel
    Kim, Jae Seung
    Kim, Sung-Bae
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Kim, Sang Yoon
    EUROPEAN JOURNAL OF CANCER, 2019, 116 : 98 - 106
  • [34] Management of Advanced-Stage Operable Esophageal Cancer
    Bharat, Ankit
    Crabtree, Traves
    SURGICAL CLINICS OF NORTH AMERICA, 2012, 92 (05) : 1179 - +
  • [35] Evaluating racial and ethnic differences in advanced-stage laryngeal cancer treatment and outcomes in Florida: Unmasking the inequities
    Washington, Caretia J.
    Lattimore, Chayil
    Braithwaite, Dejana
    Fredenburg, Kristianna
    Karanth, Shama
    CANCER RESEARCH, 2024, 84 (06)
  • [36] Survival Analysis of Patients With Advanced-Stage Oropharyngeal Cancer Stratified by Molecular Profile and Treatment
    Biron, V. L.
    O'Connell, D. A.
    Klimowicz, A. C.
    Puttagunta, L.
    Harris, J.
    Seikaly, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 529 - 529
  • [37] Can advanced-stage ovarian cancer be cured?
    Steven Narod
    Nature Reviews Clinical Oncology, 2016, 13 : 255 - 261
  • [38] Comorbidity and survival for patients with advanced-stage non-small cell lung cancer
    Chrischilles, Elizabeth A.
    Abu Hejleh, Taher
    Carter, Knute D.
    Pendergast, Jane F.
    Halfdanarson, Thorvardur Ragnar
    Fletcher, Robert H.
    Wallace, Robert B.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Enhancing Survival Outcome Predictions in Advanced-Stage Lung Cancer through Radiomics Analysis
    Wang, S.
    Marasco, J.
    Li, T.
    Lin, C.
    Oh, K.
    Lei, Y.
    Rhodd, C.
    Gallagher, K. J.
    Zhou, S. M.
    MEDICAL PHYSICS, 2024, 51 (10) : 7768 - 7768
  • [40] Management of advanced stage laryngeal cancer
    Levine, PA
    Brasnu, DF
    Ruparelia, A
    Laccourreye, O
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 1997, 30 (01) : 101 - &